Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Regulus Therapeutics Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 45 | 42 | −3 |
| Shares | 23.1M | 23.0M | −101.8K (−0.4%) |
| Value | $18.7M | $15.9M | −$2.88M (−15.4%) |
New holders (6)
Institutions that held Regulus Therapeutics Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Price T Rowe Associates Inc | 38,100 | $26.0K | 0.00% |
| UBS Group AG | 19,874 | $14.0K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 14,000 | $10.0K | 0.00% |
| Two Sigma Advisers, LP | 11,900 | $8.00K | 0.00% |
| AdvisorNet Financial, Inc | 7,500 | $5.00K | 0.00% |
| Barclays PLC | 50 | $0 | 0.00% |
Sold out (9)
Institutions that held Regulus Therapeutics Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Focused Wealth Management, Inc | 200,000 | $163.0K |
| Tower Research Capital LLC (TRC) | 91,872 | $75.0K |
| Virtu Financial LLC | 79,193 | $64.0K |
| Strategic Wealth Advisors Group, LLC | 74,800 | $61.0K |
| Jane Street Group, LLC | 59,432 | $48.0K |
| Two Sigma Securities, LLC | 37,741 | $31.0K |
| Zacks Investment Management | 28,346 | $23.0K |
| Pinz Capital Management, LP | 22,300 | $18.0K |
| Endurance Wealth Management, Inc. | 6,750 | $5.00K |